SUMMARY In 30 patients with gastrooesophageal reflux, intravenous metoclopramide (Maxolon) has been shown to increase the gastrooesophageal sphincter pressure. The rise is dose-related until a maximum pressure, proportional to the resting sphincter tone, is reached. The effect is reversed by atropine. Peristaltic waves are increased in pressure by metoclopramide.In 18 patients with gastrooesophageal reflux intravenous metoclopramide diminished the frequency of reflux episodes and increased the rate at which the oesophagus emptied itself of an acid load.Metoclopramide (Maxolon) has been shown to have a number of actions on gastrointestinal motility but little attention has been paid to its effects on the oesophagus. The one detailed study published (Heitmann and Moller, 1970) clearly demonstrates that in healthy adults the drug raises the pressure of the gastrooesophageal sphincter and increases the height and duration of peristaltic contractions in the distal oesophagus. An obvious potential application of these actions is to prevent gastrooesophageal reflux, and we have studied its effect in patients with symptoms of 'reflux oesophagitis'. in 16 men and 14 women aged 18 to 77 years (mean 51.2 years) with symptoms of gastrooesophageal reflux (heartburn, acid regurgitation, and discomfort on drinking hot fluids). Radiologically eight had been shown to have a hiatus hernia and 11 gastrooesophageal reflux, and all had abnormal gastrooesophageal reflux detected by 15-hour intraoesophageal pH recordings (Stanciu and Bennett, to be published). Three patients had previously had truncal vagotomy and pyloroplasty for duodenal ulceration.Recordings were made with the patients supine by withdrawing the previously swallowed tube assembly from the stomach to oesophagus in 0.5 cm steps. At each point in the oesophagus, pressures were recorded both during quiet breathing and during swallows. In 20 patients the procedure was repeated after the intravenous injection of 5 ml 0.9 % sodium chloride solution, and again after 10 mg metoclopramide intravenously. The patients were not aware which injection contained the drug, but had previously given consent to the study.In another 10 patients the solutions were given by continuous intravenous infusion while the distal catheter opening was held in the gastrooesophageal sphincter. At first, 0.9 % sodium chloride was infused and then metoclopramide (40 mg/100 ml saline) at increasing rates. The infusion was continued at each rate for five to six minutes. In six of these patients atropine (0.3 mg/kg) was given intravenously at the end of the metoclopramide infusion.
RESULTSThe mean resting end-expiratory gastrooesophageal sphincter pressure (average of recorded pressure in all patients) before metoclopramide was 11.8 ± SD 5.7 cm water. There was no significant change after 275 on 9 May 2018 by guest. Protected by copyright.